Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Christopher Garrison
7 POSTS
0 COMMENTS
Lessons for a pandemic preparedness treaty from previous successes and failures with treaty-based technology...
Christopher Garrison
-
October 19, 2021
We need a Global Vaccines Taskforce, not just a British or European one
Christopher Garrison
-
February 24, 2021
What is the ‘know-how gap’ problem and how might it impact scaling up production...
Christopher Garrison
-
December 16, 2020
How the ‘Oxford’ Covid-19 vaccine became the ‘AstraZeneca’ Covid-19 vaccine
Christopher Garrison
-
October 5, 2020
Price, profit and the Covid-19 health technology pool: The example of remdesivir
Christopher Garrison
-
May 28, 2020
Never say never – Why the High Income Countries that opted-out from the Art....
Christopher Garrison
-
April 8, 2020
Urgent collective action to meet the challenge of this pandemic crisis: a coronavirus related...
Christopher Garrison
-
March 30, 2020
This work is licensed under Creative Commons.